Olam plans to double African coffee estates
[SINGAPORE] Olam International, a commodity trader controlled by Singapore investment company Temasek Holdings, plans to more than double coffee-plantation acreage in Africa to improve quality control on the continent.
The company, 51.4 per cent held by Temasek, targets total African coffee farmland at 5,000 hectares (12,355 acres) from 2,200 hectares already planted in Zambia and Tanzania, Deepak Kaul, senior vice president for coffee, said by e-mail on Friday in response to questions.
In Zambia, where Olam already has 1,200 hectares planted, the company plans to increase estates to 2,700 hectares through its subsidiary, Northern Coffee, one of the biggest large scale producers in Africa, Kaul said without providing a timeframe.
"As Africa is a central part of our business, we are committed to investing and expanding on the continent," he said. Customers increasingly want "single-estate, certified and traceable coffees," MR Kaul said.
The company's farms are in their early phases of development, with planting going on and limited production so far, he said. Its Zambian unit started exports to Japan in August, he said.
Olam, which says it is the biggest originator of African coffee, has a network of 2.8 million smallholders in 24 African countries involved in cocoa, cotton, cashews, coffee, sesame, among others, Kaul said.
"With capabilities ranging from plantations to distribution and marketing, we maintain very good control over the flow and quality of the coffee we procure," MR Kaul said. "We are also actively involved in sustainability programs that support the development of local coffee communities while protecting the environment." Africa produces around 10 per cent of global coffee supply, according to the US Department of Agriculture.
BLOOMBERG
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance